MetLife Investment Management’s Inotiv NOTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,408
Closed -$142K 2839
2022
Q3
$142K Hold
8,408
﹤0.01% 2492
2022
Q2
$80.7K Hold
8,408
﹤0.01% 2762
2022
Q1
$220K Buy
8,408
+3,103
+58% +$87.1K ﹤0.01% 2299
2021
Q4
$223K Hold
5,305
﹤0.01% 1986
2021
Q3
$155K Hold
5,305
﹤0.01% 2241
2021
Q2
$142K Buy
+5,305
New +$133K ﹤0.01% 2347

Other funds holding NOTV

MetLife Investment Management's NOTV Position: Q4 2022 in Review

MetLife Investment Management sold out of Inotiv (NOTV) in Q4 2022, closing a stake of 8,408 shares — an estimated $142K sold.

MetLife Investment Management first reported a position in NOTV in Q2 2021 and held it in 6 quarters. The position peaked at $223K in Q4 2021. 80 funds tracked by Wall St. Rank hold NOTV as of Q4 2022.

  • MetLife Investment Management reported no remaining Inotiv position as of Q4 2022 after selling out during the quarter.
  • MetLife Investment Management sold 8,408 Inotiv shares in Q4 2022, an estimated $142K.
  • MetLife Investment Management first reported a position in Inotiv in Q2 2021 and held it in 6 quarters.
  • MetLife Investment Management's Inotiv position peaked at $223K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Inotiv as of Q4 2022.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.